Product Details
Features and Advantages
- Seamless Transition from Preclinical to Clinical: Same cell clone, process, and QC as GMP products.
- Enhanced Production Standards: AOF raw materials, pharma-grade excipients, Grade B+A (ISO 5) environment.
- Comprehensive Quality Control: Additional strict testing for process impurities, sterility, and mycoplasma.
- Cost-Effective Solution: GMP-comparable quality at an economical price for early development.
- Risk Mitigation: Enhanced safety through rigorous impurity control and comprehensive testing.
Source
Monoclonal Anti-Human CD28 Antibody, premium grade (CD8-M120b) is recombinantly produced from human 293 cells (HEK293).
It is produced under our rigorous quality control system that incorporates a comprehensive set of tests including sterility and endotoxin tests. Product performance is carefully validated and tested for compatibility for cell culture use or any other applications in the early preclinical stage.
GMP-MC2824 is the GMP version of this CD8-M120b. These two proteins display indistinguishable performance profiles, thereby ensuring a seamless transition for end users from early preclinical stage to later clinical phases.Isotype
Mouse IgG1 | Mouse Kappa
Conjugate
Unconjugated
Specificity
This product is a specific antibody specifically reacts with CD28.
Endotoxin
Less than 0.002 EU per μg by the LAL method / rFC method.
Protein A
<5 ppm of protein tested by ELISA.
Host Cell Protein
<0.5 ng/μg of protein tested by ELISA.
Host Cell DNA
<0.02 ng/μg of protein tested by qPCR.
Purity
>95% as determined by SDS-PAGE.
>95% as determined by SEC-MALS.
Sterility
Negative
Mycoplasma
Negative
Formulation
Supplied as 0.2 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Shipping
This product is supplied and shipped with dry ice, please inquire the shipping cost.
Storage
For long term storage, the product should be stored at liquid state at -70°C.
This product is stable after storage at:
- 2-8°C for 12 months under sterile conditions;
- -70°C for 24 months.
ACRO Quality Management System
Quality Description
ACRO's Research-grade products are suitable for a wide range of cell culture applications, particularly for research use in academic institutions. These products are sterilized by filtration, followed by lyophilization where applicable. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. Biological activity is calibrated against WHO/NIBSC standards when available.
ACRO's Premium-grade (Pre-GMP) products are characterized by their high quality and enhanced safety profiles, making them ideal for early-stage discovery and manufacturing processes in cell therapy companies. A key advantage is their seamless transition to corresponding GMP-grade versions. Biological activity is calibrated against WHO/NIBSC standards when available. Typical specifications include endotoxin levels of <0.01 EU/μg and purities >95%. In addition, rigorous testing is conducted to ensure the absence of mycoplasma, HCD, and HCP, thereby guaranteeing product safety.
Customers Also Viewed
Performance Data
SDS-PAGE

Monoclonal Anti-Human CD28 Antibody, premium grade on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).
SEC-MALS

The purity of Monoclonal Anti-Human CD28 Antibody, premium grade (Cat. No. CD8-M120b) is more than 95% and the molecular weight of this protein is around 140-160 kDa verified by SEC-MALS.
Report
Bioactivity-CELL BASE

Monoclonal Anti-Human CD28 Antibody, premium grade (Cat. No. CD8-M120b) stimulates secretion of IL-2 by PBMC stimulated with 4 ng/mL Monoclonal Anti-Human CD3 Antibody, Mouse IgG2a (Clone: OKT3), premium grade (Cat. No. CDE-M120a). The typical EC50 for this effect is 2.03 ng/mL (QC tested).
Protocol
Bioactivity-ELISA

Immobilized Human / Cynomolgus / Rhesus macaque CD28, His Tag at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Human CD28 Antibody, premium grade (Cat. No. CD8-M120b) with a linear range of 0.098-1.563 ng/mL (QC tested).
Protocol
Bioactivity-Stability

Cell-based assay demonstrates batch-to-batch consistency between Acro's GMP and PG CD28 Antibody.
Customer Reviews Writing Reviews

Background
Recent Advances
- English Name:
T-cell-specific surface glycoprotein CD28
- Category:
- Approved Drugs:
0 Details
- Drugs in Clinical Trials:
31 Details
- Highest Development Stage:
Phase 2 Clinical
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521




















